by The hospital surgical disinfectants market is estimated to be valued at US$ 3.51 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Hospital surgical disinfectants are primarily used in hospitals, surgical centers, and clinics to disinfect surfaces, equipment, medical devices, etc. These disinfectants help in preventing microbial contamination and hospital-acquired infections. Some key products in this market include skin disinfectants, surface disinfectants, instrument disinfectants etc. They are used for pre-surgical cleansing and disinfection of operating room equipment, patient skin, scalpels, forceps, etc.
Market Dynamics:
Two key drivers contributing to the growth of this market are increased emphasis on infection control and prevention in healthcare facilities and rising incidence of hospital-acquired infections. Government agencies and healthcare regulatory bodies across countries have implemented stringent guidelines and protocols for infection control and prevention in hospitals. This has increased the demand for effective disinfection and sterilization practices using surgical disinfectants. According to the Centers for Disease Control and Prevention (CDC), over 2.8 million HAI occur annually in U.S. healthcare facilities. This has driven up the adoption of disinfectants and sterilants for cleaning surgical equipment and preventing HAIs. Additionally, growing demand for surgical procedures and rise in number of healthcare settings are also fueling the growth of this market during the forecast period.
SWOT Analysis
Strength: Hospital surgical disinfectants have strong antiseptic properties that effectively kill microbes and prevent infection. Several products offer broad-spectrum coverage against viruses, bacteria, and fungi. Many brands have established their reliability and are trusted by medical professionals.
Weakness: Some disinfectants contain harsh chemicals that can irritate skin and cause allergic reactions in sensitive users. Bottles containing liquids also carry a risk of spills. Strict regulations and compliance requirements increase production costs.
Opportunity: Rising number of surgical procedures due to an aging population and growing incidence of chronic diseases is augmenting demand. Stable funding for hospital infrastructure in developing nations presents an opportunity. New product innovations focused on natural extracts or gentle formulas can potentially gain market share.
Threats: Stiff competition from substitute sterilization technologies and private label brands poses pricing pressure. Stringent regulations governing new product approvals can delay market entry. Economic slowdowns may impact hospital budget allocations for non-essential supplies.
Key Takeaways
The Hospital Surgical Disinfectants Market Growth is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to increasing number of surgical procedures performed annually across the globe. Surging caseload of chronic diseases prompting more operations as well as growing medical tourism are augmenting the market size. The global market size for hospital surgical disinfectants was valued at US$ 3.51 Bn in 2023.
Regional analysis: North America currently dominates the global market due to well-established healthcare infrastructure and higher healthcare spending. However, Asia Pacific is anticipated to witness the fastest growth over the coming years on account of rapidly expanding medical tourism industry, growing medical facilities, and rising disposable incomes in the region.
Key players related content: Key players operating in the hospital surgical disinfectants market are 3M Company, Reckitt Benckiser Group plc, Ecolab Inc., Steris plc, Cardinal Health, Becton, Dickinson and Company, Kimberly-Clark Corporation, Bio-Cide International Inc., Shandong Weigao Group Medical Polymer Company Limited, Carenow Medical Pvt. Ltd., B.Braun Melsungen AG, HARTMANN GROUP, Merck KGaA, Entaco Ltd., Medalkan, Medichem S.A., Ruhof Healthcare, Clinicept Healthcare, Integra LifeSciences Holdings Corporation, Micro-Scientific, LLC. These players are focusing on new product launches and strengthening their distribution networks to increase market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
